Delivery Order SPE2DX22D0010-SPE2D826FED60
Award Date 3/25/26
Potential Completion Date 3/26/26
Potential Value $9.5K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain issued a $17,490.51 delivery order to AmerisourceBergen Drug Corp on February 11, 2026, for Percocet tabs 10/325. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999.00 indefinite delivery contract running through December 2026 that provides pharmaceutical and medical supply support to military healthcare programs worldwide. Place of performance is Conshohocken, PA. The order has a firm fixed price structure...
- The Defense Logistics Agency's Medical Supply Chain issued a $16,367.94 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Percocet tablets (10/325 mg), with ultimate completion on March 9, 2026. Place of performance is Conshohocken, PA. The order was issued under firm fixed-price terms with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Percocet Tablets (10/325 mg) with a ceiling value of $23,778.44. This competitively awarded, firm fixed-price delivery order is classified as a child contract and represents a non-set-aside procurement. The place of performance is located at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 29,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Percocet tablets (10/325 mg) with a ceiling value of $20,054.90. This firm fixed-price delivery order, which must be completed by August 28, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Percocet tablets (10/325 mg) with a contract value of $18,171.08. This firm fixed-price delivery order is non-competitive and represents a task order under a larger Indefinite Delivery Contract vehicle. The order is scheduled for completion by January 22, 2026, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $35,778.17 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Percocet tablets (10/325 mg). This is a firm fixed-price, non-set-aside contract with a completion date of December 18, 2025, reflecting a short-term pharmaceutical delivery requirement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical...
- <p>The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on February 3, 2026, with a ceiling value of $3,128.09 for Percocet tablets (5/325 mg).</p> <p>Place of performance is Conshohocken, PA 19428. The order has a firm fixed price structure and an ultimate completion date of February 4, 2026. No set-aside was used.</p>
- The U.S. Defense Department's Medical Supply Chain awarded a $6,403.30 delivery order to AmerisourceBergen Drug Corp for Percocet tablets (5/325 mg) with a completion date of October 31, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 13, 2025, for the supply of Percocet tablets (10/325 mg) with a ceiling value of $13,210.51. This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The U.S. Defense Department's Medical Supply Chain awarded a $21,974.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Percocet tablets (5/325 mg) with an ultimate completion date of September 29, 2025. This non-set-aside competitive award was issued on September 26, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has an...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FED60Delivery Order
The Defense Logistics Agency Medical Supply Chain issued a $9,505.71 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Percocet tablets (5/325 mg), with an ultimate completion date of March 26, 2026. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis and carries no set-aside. This delivery order is issued under the parent Defense Logistics Agency Troop Support Medical Indefinite Delivery Contract, a single-award IDC valued at up to $999,999,999.00 through December 2031, which serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs.
Generated 6/23/26, 10:39 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 3/24/26 |